Victory Capital Management
ETON icon

Victory Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Victory Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,979
Closed -$123K – 2502
2023
Q4 		$123K Buy
+27,979
New +$112K ﹤0.01% 2314
2020
Q2 		– Sell
-4,858
Closed -$20K – 2755
2020
Q1 		$20K Buy
+4,858
New +$28.4K ﹤0.01% 3092
2019
Q4 		– Sell
-2,127
Closed -$13K – 2840
2019
Q3 		$13K Buy
+2,127
New +$13.6K ﹤0.01% 3175

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Victory Capital Management's ETON Position: Q1 2024 in Review

Victory Capital Management sold out of Eton Pharmaceutcials (ETON) in Q1 2024, closing a stake of 27,979 shares — an estimated $123K sold.

Victory Capital Management first reported a position in ETON in Q3 2019 and held it in 3 quarters. The position peaked at $123K in Q4 2023. 44 funds tracked by Wall St. Rank hold ETON as of Q1 2024.

  • Victory Capital Management reported no remaining Eton Pharmaceutcials position as of Q1 2024 after selling out during the quarter.
  • Victory Capital Management sold 27,979 Eton Pharmaceutcials shares in Q1 2024, an estimated $123K.
  • Victory Capital Management first reported a position in Eton Pharmaceutcials in Q3 2019 and held it in 3 quarters.
  • Victory Capital Management's Eton Pharmaceutcials position peaked at $123K in Q4 2023.
  • 44 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2024.

Based on Victory Capital Management's 13F filing for Q1 2024, filed 3 May 2024.